1–10 of 11 results for Carl J Danzig
Efficacy, Safety, and Durability of Faricimab in Macular Edema Due to Retinal Vein Occlusion:72-Week Results From the Phase 3 BALATON and COMINO Trials
Carl J Danzig, MD
Updates from the Field
2024
Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Annual Meeting Talks
2022
Clinical Trial Versus Real-World Outcomes With Anti-VEGF Therapy for Branch and Central Retinal Vein Occlusion
2021
Clinical Effects of Blocking Ang-2 and VEGF with Faricimab in the Phase 2 STAIRWAY Trial
2020
Part 3: Implementing Clinical Trials in a Retina Practice: How to Get Started and Recruit Successfully (Part 3 of 3)
Arshad M. Khanani, MD, MA, FASRS
Charles C Wykoff, MD, PhD, FASRS
John D Pitcher, MD
Nikolas JS London, MD, FACS, FASRS
On Demand Cases, Courses, and Papers
2018
Part 2: Implementing Clinical Trials in a Retina Practice: How to Get Started and Recruit Successfully (Part 2 of 3)
Part 1: Implementing Clinical Trials in a Retina Practice: How to Get Started and Recruit Successfully (Part 1 of 3)
Part 3: Panel Discussion: Implementing Clinical Trials in a Retina Practice: How to get started and recruit successfully (Part 3 of 3)
2017
Part 2: Recruitment & Retention of Patients in Clinical Trials; Principal Investigator Responsibilities in Clinical Trials; and Clinical Trials in a Large Practice Setting (Part 2 of 3)